Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:22 pm Purchase | 2022-12-31 | 13G | Replimune Group, Inc. REPL | Redmile Group, LLC | 5,740,099 9.900% | 574,968 (+11.13%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Redmile Group, LLC | 459,980 9.900% | 60,059 (+15.02%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Redmile Group, LLC | 4,899,772 9.900% | 1,941,488 (+65.63%) | Filing History |
| 2023-02-14 4:21 pm Sale | 2022-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | Redmile Group, LLC | 151,528 6.900% | -64,550 (-29.87%) | Filing History |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | ImmunoGen, Inc. IMGN | Redmile Group, LLC | 19,896,453 8.600% | 274,472 (+1.40%) | Filing History |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Redmile Group, LLC | 8,483,322 9.900% | 1,217,808 (+16.76%) | Filing History |
| 2023-02-14 4:19 pm Purchase | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Redmile Group, LLC | 7,108,097 9.900% | 1,427,180 (+25.12%) | Filing History |
| 2023-02-14 4:18 pm Purchase | 2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Redmile Group, LLC | 393,500 9.900% | 29,551 (+8.12%) | Filing History |
| 2023-02-14 4:18 pm Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | Redmile Group, LLC | 4,897,575 9.900% | 5,882 (+0.12%) | Filing History |
| 2023-02-14 4:16 pm Purchase | 2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Redmile Group, LLC | 28,599,494 9.900% | 194,452 (+0.68%) | Filing History |
| 2023-02-10 5:18 pm Purchase | 2022-12-31 | 13G | ADC Therapeutics S.A. ADCT | Redmile Group, LLC | 13,565,249 16.800% | 6,114,220 (+82.06%) | Filing History |
| 2023-02-08 5:18 pm Purchase | 2023-01-19 | 13G | Ayala Pharmaceuticals, Inc. ADXS | Redmile Group, LLC | 332,353 6.800% | 332,353 (New Position) | Filing History |
| 2023-02-08 5:16 pm Sale | 2022-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA | Redmile Group, LLC | 0 0.000% | -1,472,522 (Position Closed) | Filing History |
| 2023-02-03 5:16 pm Purchase | 2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK | Redmile Group, LLC | 4,166,975 9.700% | 1,920,307 (+85.47%) | Filing History |
| 2022-11-18 5:18 pm Purchase | 2022-11-14 | 13G | Scholar Rock Holding Corporation SRRK | Redmile Group, LLC | 5,531,000 9.900% | 178,795 (+3.34%) | Filing History |
| 2022-11-18 5:17 pm Purchase | 2022-11-14 | 13G | Replimune Group, Inc. REPL | Redmile Group, LLC | 5,165,131 9.900% | 389,670 (+8.16%) | Filing History |
| 2022-10-17 5:15 pm Purchase | 2022-10-13 | 13G | Zymeworks Inc. ZYME | Redmile Group, LLC | 6,075,918 10.100% | 6,075,918 (New Position) | Filing History |
| 2022-10-05 5:00 pm Purchase | 2022-10-03 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,377,090 11.600% | 14,630 (+0.44%) | Filing History |
| 2022-09-02 4:36 pm Unchanged | 2022-09-01 | 13D | Augmedix, Inc. AUGX | Redmile Group, LLC | 15,871,125 40.800% | 0 (Unchanged) | Filing History |
| 2022-08-08 5:15 pm Purchase | 2022-07-29 | 13G | Zymeworks Inc. ZYME | Redmile Group, LLC | 5,758,241 9.900% | 5,758,241 (New Position) | Filing History |